22 results on '"Adipocyte hypertrophy"'
Search Results
2. Heightened TPD52 linked to metabolic dysfunction and associated abnormalities in zebrafish.
- Author
-
Lai HH, Jeng KS, Huang CT, Chu AJ, and Her GM
- Subjects
- Animals, Adipogenesis genetics, Neoplasm Proteins metabolism, Neoplasm Proteins genetics, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease genetics, Non-alcoholic Fatty Liver Disease pathology, Lipogenesis, Cardiomyopathies metabolism, Cardiomyopathies genetics, Cardiomyopathies pathology, Proto-Oncogene Mas, Metabolic Diseases metabolism, Metabolic Diseases genetics, Metabolic Diseases pathology, Zebrafish Proteins genetics, Zebrafish Proteins metabolism, Cell Differentiation, Lipid Metabolism, Zebrafish metabolism, Animals, Genetically Modified, Adipocytes metabolism
- Abstract
The tumor protein D52 (TPD52) gene encodes a proto-oncogene protein associated with various medical conditions, including breast and prostate cancers. It plays a role in multiple biological pathways such as cell growth, differentiation, and apoptosis. The function of TPD52 in lipid droplet biosynthesis has been investigated in vitro. However, its precise role in lipid metabolism in animal models is not fully understood. To investigate the functions of TPD52 in vivo, we performed a conditional TPD52 protein expression analysis using a Tet-off transgenic system to establish conditionally expressed Tpd52 transgenic zebrafish. The effect of Tpd52 on lipogenesis was assessed using various methods, including whole-mount Oil Red O staining, histological examination, and measurement of inflammatory markers and potential targets using real-time quantitative polymerase chain reaction and immunoblotting in Tpd52 fish. Zebrafish with increased Tpd52 levels exhibited notable weight gain and the enlargement of fat deposits, which were mainly attributed to an increase in the volume of adipocytes. Moreover, Tpd52 overexpression was correlated with the triggering of the adipocyte differentiation signaling pathway. During adipocytic differentiation in response to nutrient status, our observations revealed adipogenesis, nonalcoholic fatty liver disease, and metabolic cardiomyopathy (MCM) in Tpd52 transgenic zebrafish. To gain a deeper understanding of the contribution of these proteins to the regulation of cellular growth, we investigated the expression of their corresponding genes and proteins in zebrafish. In the present study, the activated protein kinase pathway was identified as the primary target of TPD52. Adult Tpd52 zebrafish showed increased lipid accumulation, resulting in the development of visceral obesity, nonalcoholic fatty liver disease, and MCM. These findings strongly suggest that TPD52 actively contributes to adipose tissue expansion and its subsequent effects. This investigation provides compelling evidence that Tpd52 facilitates adipocyte development and related metabolic comorbidities in zebrafish., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Adipose failure through adipocyte overload and autoimmunity.
- Author
-
Susca N, Leone P, Prete M, Cozzio S, and Racanelli V
- Subjects
- Humans, Obesity immunology, Obesity metabolism, Animals, Metabolic Syndrome immunology, Metabolic Syndrome metabolism, Insulin Resistance immunology, Adiposity immunology, Adipocytes immunology, Adipocytes metabolism, Autoimmunity immunology, Adipose Tissue immunology, Adipose Tissue metabolism
- Abstract
Metabolic syndrome poses a great worldwide threat to the health of the patients. Increased visceral adiposity is recognized as the main determinant of the detrimental clinical effects of insulin resistance. Inflammation and immune system activation in the adipose tissue (AT) have a central role in the pathophysiology of metabolic syndrome, but the mechanisms linking increased adiposity to immunity in the AT remain in part elusive. In this review, we support the central role of adipocyte overload and relative adipose failure as key determinants in triggering immune aggression to AT. This provides a mechanistic explanation of the relative metabolic wellness of metabolically normal obese people and the disruption in insulin signaling in metabolically obese lean people., Competing Interests: Declaration of Competing Interest None., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Nobiletin suppresses monocyte chemoattractant protein-1 (MCP-1) expression by regulating MAPK signaling in 3T3-L1 cells
- Author
-
Sho Yasunaga, Miku Domen, Kosuke Nishi, Ayumu Kadota, and Takuya Sugahara
- Subjects
Nobiletin ,MCP-1 ,Chemokines ,Adipocyte hypertrophy ,3T3-L1 cells ,Tumor necrosis factor α ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Nobiletin is a major citrus flavonoid possessing several biological activities. Nobiletin has been reported to display anti-inflammatory activity and to reduce monocyte chemoattractant protein (MCP)-1 secretion by 3T3-L1 adipocytes. However, its mode of action remains unclear. In the present study, we investigated the suppressive effect of nobiletin on MCP-1 expression in 3T3-L1 cells and its underlying molecular mechanism. Nobiletin notably down-regulated the MCP-1 mRNA level during adipocyte differentiation. Nobiletin also reduced MCP-1 secretion by preadipocytes (undifferentiated cells), differentiated adipocytes, and hypertrophied adipocytes. Immunoblot analysis showed that nobiletin inhibits the phosphorylation level of extracellular signal-regulated kinase (ERK) in both preadipocytes and differentiated adipocytes. Moreover, nobiletin suppressed MCP-1 secretion by adipocytes induced by tumor necrosis factor (TNF)-α.
- Published
- 2016
- Full Text
- View/download PDF
5. Gestational exposure to bisphenol S induces microvesicular steatosis in male rat offspring by modulating metaflammation.
- Author
-
Molangiri A, Varma S, Hridayanka KSN, Srinivas M, Kona SR, Ibrahim A, Duttaroy AK, and Basak S
- Subjects
- Pregnancy, Female, Rats, Male, Animals, Humans, Rats, Wistar, Cyclooxygenase 2, Interleukin-6, Inflammation chemically induced, Cholesterol, Hypertrophy, Benzhydryl Compounds toxicity, Fatty Liver chemically induced, Fatty Liver pathology, Prenatal Exposure Delayed Effects chemically induced
- Abstract
Prenatal exposure to endocrine-disrupting bisphenol A (BPA) shows a long-lasting programming effect on an organ's metabolic function and predisposes it to the risk of adult metabolic diseases. Although a reduced contaminant risk due to "BPA-free" exposure is proposed, limited data on a comparative assessment of gestational exposure to BPS and BPA and their effects on metaflammation in predisposing liver metabolic disease is reported. Pregnant Wistar rats were exposed to BPS and BPA (0.0, 0.4, 4.0 μg/kg bw) via gavage from gestational day 4 to 21, and effects were assessed in the 90 d male offspring. Prenatal BPS-exposed offspring showed a more obesogenic effect than BPA, including changes in body fat distribution, feed efficiency, and leptin signalling. The BPS exposure induced the adipocyte hypertrophy of visceral adipose to a greater extent than BPA. The adipose hypertrophy was augmented by tissue inflammation, endoplasmic reticulum (ER) stress, and apoptosis due to increased expression of pro-inflammatory (IL6, IL1β, CRP, COX2) cytokines, ER stress modulator (CHOP), and apoptotic effector (Caspase 3). The enlarged, stressed, inflamed adipocytes triggered de novo lipogenesis in the bisphenol-exposed offspring liver due to increased expression of cholesterol and lipid biogenesis mediators (srebf1, fasn, acaca, PPARα) concomitant with elevated triacylglycerol (TG) and cholesterol (TC), resulted in impaired hepatic clearance of lipids. The lipogenic effects were also promoted by increased expression of HSD11β1. BPS exposure increased absolute liver weight, discoloration, altered liver lobes more than in BPA. Liver histology showed numerous lipid droplets, and hepatocyte ballooning, upregulated ADRP expression, an increased expression of pro-inflammatory mediators (IL6, CRP, IL1β, TNFα, COX2), enhanced lipid peroxidation in the BPS-exposed offspring's liver suggest altered metaflammation leads to microvesicular steatosis. Overall, gestational BPS exposure demonstrated a higher disruption in metabolic changes than BPA, involving excess adiposity, liver fat, inflammation, and predisposition to steatosis in the adult male offspring., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
6. Short communication: In ovo injection of all-trans retinoic acid causes adipocyte hypertrophy in embryos but lost its effect in posthatch chickens.
- Author
-
Kim DH, Lee J, Lee C, Shin BJ, Ryu BY, and Lee K
- Subjects
- Chick Embryo, Animals, Tretinoin, Hypertrophy veterinary, Adipocytes, Mammals, Chickens physiology, Ovum
- Abstract
The regulation of adipose deposition in broiler chickens is an important factor for production efficiency to poultry producers and health concerns to customers. Although vitamin A and its metabolite [all-trans retinoic acid (atRA)] have been used for studies on adipogenesis in mammals and avian, effects of embryonic atRA on adipose development in embryonic (E) and posthatch (D) ages in broiler chickens have not been studied yet. Different concentrations of atRA (0 M-2 μM) were injected in broiler eggs at E10, and adipose tissues were sampled at E16. Percentages of adipose tissues in chicken embryos were significantly increased in the group injected with 500 nM of atRA compared to the 0 M group (P < 0.05). In addition, the adipocyte cross-sectional area (CSA) was significantly greater by in ovo injection of 500 nM atRA compared to the injection of 0 M (P < 0.01). Moreover, in ovo atRA-injected embryos were hatched and BWs were measured at D0, D7, and D14. BWs were not different from those of the 0 M group. Percentages of adipose tissues and CSA of the in ovo atRA-injected group (500 nM) were not different from those of the 0 M group at D14. Taken together, the current study clearly showed that in ovo injection of atRA promoted adipose deposition with hypertrophy during embryonic development, but its effects were not maintained in early posthatch age in broiler chickens, implying that embryonic atRA has an important role in the regulation of adipose development in chicken embryos., (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
7. Adipocyte-hepatocyte crosstalk in cellular models of obesity: Role of soluble factors.
- Author
-
Baldini F, Diab F, Serale N, Zeaiter L, Portincasa P, Diaspro A, and Vergani L
- Subjects
- Humans, Obesity metabolism, Hepatocytes metabolism, Hypertrophy metabolism, Adipokines metabolism, Fatty Acids metabolism, Triglycerides metabolism, Adipocytes metabolism, Non-alcoholic Fatty Liver Disease metabolism
- Abstract
Hepatic steatosis is often a consequence of obesity. Adipose tissue is an important endocrine regulator of metabolic homeostasis in the body. In obesity, adipocytes become hypertrophic and develop an inflammatory phenotype, altering the panel of secreted adipokines. Moreover, excess fatty acids are, in part, released by adipocytes and delivered to the liver. These multiple pathways of adipose-liver crosstalk contribute to the development and progression of liver disease: TNFα induces hepatocyte dysfunction, excess of circulating fatty acids promotes hepatic steatosis and inflammation, whilst adipokines mediate and exacerbate liver injury. In this study, we investigated in vitro the effects and mechanisms of the crosstalk between adipocytes and hepatocytes, as a function of the different adipocyte status (mature vs hypertrophic) being mediated by soluble factors. We employed the conditioned medium method to test how mature and hypertrophic adipocytes distinctively affect the liver, leading to metabolic dysfunction. The media collected from adipocytes were characterized by high triglyceride content and led to lipid accumulation and fat-dependent dysfunction in hepatocytes. The present findings seem to suggest that, in addition to triglycerides, other soluble mediators, cytokines, are released by mature and hypertrophic adipocytes and influence the metabolic status of liver cells. Understanding the precise factors involved in the pathogenesis and pathophysiology of NAFLD in obesity will provide important insights into the mechanisms responsible for the metabolic complications of obesity, paving the way for new possible approaches., (Copyright © 2023. Published by Elsevier Inc.)
- Published
- 2023
- Full Text
- View/download PDF
8. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
- Author
-
Saverio Cinti, Grant Mitchell, Giorgio Barbatelli, Incoronata Murano, Enzo Ceresi, Emanuela Faloia, Shupei Wang, Melanie Fortier, Andrew S. Greenberg, and Martin S. Obin
- Subjects
obesity ,inflammation ,apoptosis ,necrosis ,adipocyte hypertrophy ,multinucleate giant cells ,Biochemistry ,QD415-436 - Abstract
Macrophage infiltration of white adipose tissue (WAT) is implicated in the metabolic complications of obesity. The precipitating event(s) and function(s) of macrophage infiltration into WAT are unknown. We demonstrate that >90% of all macrophages in WAT of obese mice and humans are localized to dead adipocytes, where they fuse to form syncytia that sequester and scavenge the residual “free” adipocyte lipid droplet and ultimately form multinucleate giant cells, a hallmark of chronic inflammation. Adipocyte death increases in obese (db/db) mice (30-fold) and humans and exhibits ultrastructural features of necrosis (but not apoptosis). These observations identify necrotic-like adipocyte death as a pathologic hallmark of obesity and suggest that scavenging of adipocyte debris is an important function of WAT macrophages in obese individuals. The frequency of adipocyte death is positively correlated with increased adipocyte size in obese mice and humans and in hormone-sensitive lipase-deficient (HSL−/−) mice, a model of adipocyte hypertrophy without increased adipose mass. WAT of HSL−/− mice exhibited a 15-fold increase in necrotic-like adipocyte death and formation of macrophage syncytia, coincident with increased tumor necrosis factor-α gene expression.These results provide a novel framework for understanding macrophage recruitment, function, and persistence in WAT of obese individuals.
- Published
- 2005
- Full Text
- View/download PDF
9. Targeted SHP-1 Silencing Modulates the Macrophage Phenotype, Leading to Metabolic Improvement in Dietary Obese Mice
- Author
-
Avinash Bajaj, Farah Khan, Prabhu Srinivas Yavvari, Altaf Ahmad, Yadhu Sharma, and Sandeep Kumar Muwal
- Subjects
0301 basic medicine ,obesity ,animal structures ,Population ,Phenotypic switching ,Adipose tissue ,Protein tyrosine phosphatase ,Biology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Drug Discovery ,Gene silencing ,Macrophage ,adipose tissue macrophage ,education ,education.field_of_study ,glucan particles ,lcsh:RM1-950 ,targeted delivery ,Phenotype ,030104 developmental biology ,lcsh:Therapeutics. Pharmacology ,siRNA ,030220 oncology & carcinogenesis ,SHP-1 ,Cancer research ,Molecular Medicine ,Adipocyte hypertrophy - Abstract
Chronic over-nutrition promotes adipocyte hypertrophy that creates inflammatory milieu leading to macrophage infiltration and their phenotypic switching during obesity. The SH2 domain-containing protein tyrosine phosphatase 1 (SHP-1) has been identified as an important player in inflammatory diseases involving macrophages. However, the role of SHP-1 in modulating the macrophage phenotype has not been elucidated yet. In the present work, we show that adipose tissue macrophage (ATM)-specific deletion of SHP-1 using glucan particle-loaded siRNA improves the metabolic phenotype in dietary obese insulin-resistant mice. The molecular mechanism involves AT remodeling via reducing crown-like structure formation and balancing the pro-inflammatory (M1) and anti-inflammatory macrophage (M2) population. Therefore, targeting ATM-specific SHP-1 using glucan-particle-loaded SHP-1 antagonists could be of immense therapeutic use for the treatment of obesity-associated insulin resistance., Graphical Abstract
- Published
- 2019
10. Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells
- Author
-
Carey N. Lumeng, Callie A.S. Corsa, Devika P. Bagchi, Akira Nishii, Ziru Li, Hiroyuki Mori, Julie Hardij, Jennifer B. DelProposto, Ormond A. MacDougald, and Brian S. Learman
- Subjects
eWAT, epididymal white adipose tissue ,0301 basic medicine ,HFD, high-fat diet ,β-cat−/−, adipocyte-specific β-catenin knockout ,Gene Expression ,Adipose tissue ,MSC, mesenchymal stem cell ,iWAT, inguinal white adipose tissue ,Mice ,chemistry.chemical_compound ,0302 clinical medicine ,Adipocyte ,Adipocytes ,Transcriptional regulation ,Wnt Signaling Pathway ,Cells, Cultured ,beta Catenin ,SVC, stromal-vascular cell ,Mice, Knockout ,Adipogenesis ,Basic Helix-Loop-Helix Leucine Zipper Transcription Factors ,SVF, stromal-vascular fraction ,Wnt signaling pathway ,WAT, white adipose tissue ,Cell Differentiation ,Cell biology ,pWAT, perirenal white adipose tissue ,TCF/LEF, T-cell factor/lymphoid enhancer-binding factor ,Lipogenesis ,Original Article ,Sterol Regulatory Element Binding Protein 1 ,lcsh:Internal medicine ,TAG, triacylglycerol ,030209 endocrinology & metabolism ,DNL, de novo lipogenesis ,Wnt1 Protein ,Biology ,03 medical and health sciences ,sEV, small extracellular vesicle ,Animals ,Obesity ,lcsh:RC31-1245 ,Molecular Biology ,NCD, normal chow diet ,Lipid metabolism ,Cell Biology ,β-catenin ,Lipid Metabolism ,Wnt signaling ,BAT, brown adipose tissue ,030104 developmental biology ,Metabolism ,Gene Expression Regulation ,chemistry ,LRP, low-density lipoprotein receptor-related protein ,Stromal Cells ,Adipocyte hypertrophy - Abstract
Objective Canonical Wnt/β-catenin signaling is a well-studied endogenous regulator of mesenchymal cell fate determination, promoting osteoblastogenesis and inhibiting adipogenesis. However, emerging genetic evidence in humans links a number of Wnt pathway members to body fat distribution, obesity, and metabolic dysfunction, suggesting that this pathway also functions in adipocytes. Recent studies in mice have uncovered compelling evidence that the Wnt signaling pathway plays important roles in adipocyte metabolism, particularly under obesogenic conditions. However, complexities in Wnt signaling and differences in experimental models and approaches have thus far limited our understanding of its specific roles in this context. Methods To investigate roles of the canonical Wnt pathway in the regulation of adipocyte metabolism, we generated adipocyte-specific β-catenin (β-cat) knockout mouse and cultured cell models. We used RNA sequencing, ChIP sequencing, and molecular approaches to assess expression of Wnt targets and lipogenic genes. We then used functional assays to evaluate effects of β-catenin deficiency on adipocyte metabolism, including lipid and carbohydrate handling. In mice maintained on normal chow and high-fat diets, we assessed the cellular and functional consequences of adipocyte-specific β-catenin deletion on adipose tissues and systemic metabolism. Results We report that in adipocytes, the canonical Wnt/β-catenin pathway regulates de novo lipogenesis (DNL) and fatty acid monounsaturation. Further, β-catenin mediates effects of Wnt signaling on lipid metabolism in part by transcriptional regulation of Mlxipl and Srebf1. Intriguingly, adipocyte-specific loss of β-catenin is sensed and defended by CD45-/CD31- stromal cells to maintain tissue-wide Wnt signaling homeostasis in chow-fed mice. With long-term high-fat diet, this compensatory mechanism is overridden, revealing that β-catenin deletion promotes resistance to diet-induced obesity and adipocyte hypertrophy and subsequent protection from metabolic dysfunction. Conclusions Taken together, our studies demonstrate that Wnt signaling in adipocytes is required for lipogenic gene expression, de novo lipogenesis, and lipid desaturation. In addition, adipose tissues rigorously defend Wnt signaling homeostasis under standard nutritional conditions, such that stromal-vascular cells sense and compensate for adipocyte-specific loss. These findings underscore the critical importance of this pathway in adipocyte lipid metabolism and adipose tissue function., Graphical abstract Image 1, Highlights • Wnt/β-catenin signaling regulates lipogenesis and lipid unsaturation in adipocytes. • Effects on lipogenesis are mediated in part by the regulation of Mlxipl and Srebf1. • Loss of adipocyte β-catenin is defended by CD45-/CD31- cells in chow-fed mice. • β-cat−/− mice are protected from diet-induced obesity and metabolic dysfunction.
- Published
- 2020
11. Wntless regulates lipogenic gene expression in adipocytes and protects against diet-induced metabolic dysfunction
- Author
-
Steven M. Romanelli, Kenneth T. Lewis, Devika P. Bagchi, Ormond A. MacDougald, Hiroyuki Mori, Julie Hardij, Brian S. Learman, Callie A.S. Corsa, Rebecca L. Schill, and Ziru Li
- Subjects
0301 basic medicine ,WAT, White adipose tissue ,NCD, Normal chow diet ,MSC, Mesenchymal stem cell ,Adipose tissue ,eWAT, Epididymal white adipose tissue ,SVF, Stromal-vascular fraction ,Receptors, G-Protein-Coupled ,Mice ,chemistry.chemical_compound ,0302 clinical medicine ,Adipocyte ,Adipocytes ,Wntless ,Insulin ,Glucose homeostasis ,Wnt Signaling Pathway ,TAG, Triacylglycerol ,Cells, Cultured ,Mice, Knockout ,Wls-/-, Adipocyte-specific Wntless knockout mice ,Wnt signaling pathway ,Immunohistochemistry ,Cell biology ,Adipogenesis ,Lipogenesis ,Knockout mouse ,Original Article ,Disease Susceptibility ,HFD, High-fat diet ,lcsh:Internal medicine ,030209 endocrinology & metabolism ,DNL, de novo lipogenesis ,Biology ,SVC, Stromal-vascular cells ,03 medical and health sciences ,ER, Endoplasmic reticulum ,Metabolic Diseases ,BAT, Brown adipose tissue ,Animals ,lcsh:RC31-1245 ,Molecular Biology ,Cell Biology ,Lipid Metabolism ,Wnt signaling ,Diet ,Disease Models, Animal ,Glucose ,030104 developmental biology ,Metabolism ,Gene Expression Regulation ,chemistry ,Adipocyte hypertrophy ,iWAT, Inguinal white adipose tissue ,Biomarkers - Abstract
Objective Obesity is a key risk factor for many secondary chronic illnesses, including type 2 diabetes and cardiovascular disease. Canonical Wnt/β-catenin signaling is established as an important endogenous inhibitor of adipogenesis. This pathway is operative in mature adipocytes; however, its roles in this context remain unclear due to complexities of Wnt signaling and differences in experimental models. In this study, we used novel cultured cell and mouse models to investigate functional roles of Wnts secreted from adipocytes. Methods We generated adipocyte-specific Wntless (Wls) knockout mice and cultured cell models to investigate molecular and metabolic consequences of disrupting Wnt secretion from mature adipocytes. To characterize Wls-deficient cultured adipocytes, we evaluated the expression of Wnt target and lipogenic genes and the downstream functional effects on carbohydrate and lipid metabolism. We also investigated the impact of adipocyte-specific Wls deletion on adipose tissues and global glucose metabolism in mice fed normal chow or high-fat diets. Results Many aspects of the Wnt signaling apparatus are expressed and operative in mature adipocytes, including the Wnt chaperone Wntless. Deletion of Wntless in cultured adipocytes results in the inhibition of de novo lipogenesis and lipid monounsaturation, likely through repression of Srebf1 (SREBP1c) and Mlxipl (ChREBP) and impaired cleavage of immature SREBP1c into its active form. Adipocyte-specific Wls knockout mice (Wls-/-) have lipogenic gene expression in adipose tissues and isolated adipocytes similar to that of controls when fed a normal chow diet. However, closer investigation reveals that a subset of Wnts and downstream signaling targets are upregulated within stromal-vascular cells of Wls-/- mice, suggesting that adipose tissues defend loss of Wnt secretion from adipocytes. Interestingly, this compensation is lost with long-term high-fat diet challenges. Thus, after six months of a high-fat diet, Wls-/- mice are characterized by decreased adipocyte lipogenic gene expression, reduced visceral adiposity, and improved glucose homeostasis. Conclusions Taken together, these studies demonstrate that adipocyte-derived Wnts regulate de novo lipogenesis and lipid desaturation and coordinate the expression of lipogenic genes in adipose tissues. In addition, we report that Wnt signaling within adipose tissues is defended, such that a loss of Wnt secretion from adipocytes is sensed and compensated for by neighboring stromal-vascular cells. With chronic overnutrition, this compensatory mechanism is lost, revealing that Wls-/- mice are resistant to diet-induced obesity, adipocyte hypertrophy, and metabolic dysfunction., Graphical abstract Image 1, Highlights • Wntless in adipocytes is required for the expression of a network of lipogenic genes. • Regulation of lipogenic genes by Wntless is likely mediated by Srebf1 and Mlxipl. • Adipose tissues defend loss of adipocyte-derived Wnt secretion. • Compensation for Wntless deficiency is lost with diet-induced obesity. • Wntless deficiency causes reduced adipocyte size and improved metabolic function.
- Published
- 2020
12. Bacupari peel extracts (Garcinia brasiliensis) reduce high-fat diet-induced obesity in rats
- Author
-
Renata Celi Lopes Toledo, Dorina Isabel Gomes Natal, Leandro Licursi de Oliveira, Jacinto Demuner Antônio, Maria Eliza de Castro Moreira, Dayana Alves Rodrigues, Sônia Machado Rocha Ribeiro, Hércia Stampini Duarte Martino, Marcelo Henrique dos Santos, Laércio dos Anjos Benjamin, Marcia Paranho Veloso, and Natalia Medina Ramírez
- Subjects
0301 basic medicine ,Agonist ,medicine.medical_specialty ,PPAR-γ ,Antioxidant ,medicine.drug_class ,medicine.medical_treatment ,Medicine (miscellaneous) ,Peroxisome proliferator-activated receptor ,03 medical and health sciences ,Internal medicine ,medicine ,TX341-641 ,Receptor ,Adiposity ,chemistry.chemical_classification ,Inflammation ,Lipoprotein lipase ,Nutrition and Dietetics ,biology ,Chemistry ,Nutrition. Foods and food supply ,Fatty acid synthase ,030104 developmental biology ,Endocrinology ,TNF-α ,biology.protein ,Adipocyte hypertrophy ,medicine.symptom ,Weight gain ,Food Science - Abstract
The aim of this study was to determine the effect of ethanol extract of bacupari peel (EEB) on the adiposity and inflammation modulation in obese Wistar rats. The group treated with high fat diet plus EEB (BHFD) presented weight gain, visceral fat, and lee, and an adiposity index similar to the negative control group (AIN-93M). Also, the BHFD group showed antioxidant and anti-inflammatory effect, increase of peroxisome proliferator activated receptor-γ (PPAR-γ) and Interleukin-10 (IL-10) expression, and decreasing expression of lipoprotein lipase (LPL) and fatty acid synthase (FAS), and reduced the tumor necrosis factor-α (TNF-α), blood levels of glucose, alanine aminotransferase, and adipocyte hypertrophy. The molecular docking showed that morelloflavone and 7-epiclusianone compounds from bacupari extract interacted with PPAR-γ receptor, hydrophobic interaction, indicating an agonist activity of these compounds. Thus, we demonstrated that extract of bacupari presented anti-obesity activities.
- Published
- 2017
13. Adipose Tissue
- Author
-
Gema Frühbeck, Victoria Catalán, and Xabier Unamuno
- Subjects
medicine.medical_specialty ,Fatty liver ,Adipose tissue ,Adipokine ,Inflammation ,Biology ,medicine.disease ,Extracellular matrix ,Endocrinology ,Fibrosis ,Internal medicine ,Pleiotropism ,medicine ,medicine.symptom ,Adipocyte hypertrophy - Abstract
Adipose tissue (AT) is considered one of the largest endocrine organs in the body as well as an active tissue for cellular reactions and metabolic homeostasis rather than an inert tissue for energy storage. The functional pleiotropism of AT relies on its ability to synthesize and release a large number of hormones, cytokines, extracellular matrix proteins and growth and vasoactive factors, collectively termed adipokines, that influence a variety of physiological and pathophysiological processes. AT dysfunctionality is clearly associated to the onset of important pathologies including obesity, type 2 diabetes, dyslipidemia or nonalcoholic fatty liver. The mechanisms underlying AT dysfunctionality include adipocyte hypertrophy and hyperplasia, AT inflammation, impaired extracellular matrix remodeling and fibrosis together with an altered secretion of adipokines. Recently, the potential role of brown AT as a secretory organ in the protection against obesity has been also recognized.
- Published
- 2019
14. Adipose tissue metabolism and inflammation in obesity
- Author
-
Gijs H. Goossens, Ellen E. Blaak, and Rens L. J. van Meijel
- Subjects
medicine.medical_specialty ,business.industry ,Adipose tissue ,Inflammation ,Lipid metabolism ,medicine.disease ,Extracellular matrix ,Endocrinology ,Insulin resistance ,Internal medicine ,Sarcopenia ,medicine ,Endocrine system ,medicine.symptom ,Adipocyte hypertrophy ,business - Abstract
Adipose tissue is a highly dynamic, metabolically active organ involved in a multitude of physiological processes. The expansion of adipose tissue during the development of obesity is often accompanied by adipose tissue dysfunction, which in turn contributes to metabolic and endocrine derangements. Indeed, adipose tissue dysfunction, which is characterized by adipocyte hypertrophy, impaired lipid metabolism, inflammation, a disproportionate deposition of extracellular matrix components, and inadequate vascularization, seems to play a prominent role in insulin resistance and systemic low-grade inflammation. In this chapter, the metabolic and immunological consequences of adipose tissue dysfunction in obesity are discussed. Moreover, we will elaborate on the possible link between adipose tissue dysfunction and lung diseases. Targeting adipose tissue dysfunction may provide a valuable strategy to improve cardiometabolic health and pulmonary function in obese individuals and individuals with sarcopenia, who are characterized by a relative excess of adipose tissue.
- Published
- 2019
15. Adipocyte hypertrophy parallels alterations of mitochondrial status in a cell model for adipose tissue dysfunction in obesity.
- Author
-
Baldini F, Fabbri R, Eberhagen C, Voci A, Portincasa P, Zischka H, and Vergani L
- Subjects
- 3T3-L1 Cells, Animals, Cell Differentiation, Electron Transport physiology, Hypertrophy, Mice, Oxidative Stress physiology, Oxygen Consumption physiology, Adipocytes pathology, Adipose Tissue pathology, Mitochondria pathology, Obesity physiopathology
- Abstract
Aims: Adipocyte hypertrophy is the main cause of obesity. A deeper understanding of the molecular mechanisms regulating adipocyte dysfunction may help to plan strategies to treat/prevent obesity and its metabolic complications. Here, we investigated in vitro the molecular alterations associated with early adipocyte hypertrophy, focusing on mitochondrial dysfunction., Main Methods: As model of adipocyte hypertrophy, we employed 3T3-L1 preadipocytes firstly differentiated into mature adipocytes, then cultured with long-chain fatty acids. As a function of differentiation and hypertrophy, we assessed triglyceride content, lipid droplet size, radical homeostasis by spectrophotometry and microscopy, as well as the expression of PPARγ, adiponectin and metallothioneins. Mitochondrial status was investigated by electron microscopy, oxygraph 2 k (O2K) high-resolution respirometry, fluorimetry and western blot., Key Findings: Compared to mature adipocytes, hypertrophic adipocytes showed increased triglyceride accumulation and lipid peroxidation, larger or unique lipid droplet, up-regulated expression of PPARγ, adiponectin and metallothioneins. At mitochondrial level, early-hypertrophic adipocytes exhibited: (i) impaired mitochondrial oxygen consumption with parallel reduction in the mitochondrial complexes; (ii) no changes in citrate synthase and HSP60 expression, and in the inner mitochondrial membrane polarization; (iii) no stimulation of mitochondrial fatty acid oxidation. Our findings indicate that the content, integrity, and catabolic activity of mitochondria were rather unchanged in early hypertrophic adipocytes, while oxygen consumption and oxidant production were altered., Significance: In the model of early adipocyte hypertrophy exacerbated oxidative stress and impaired mitochondrial respiration were observed, likely depending on reduction in the mitochondrial complexes, without changes in mitochondrial mass and integrity., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
16. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes[S]
- Author
-
Aki Teraminami, Tsuyoshi Goto, Shizuka Hirai, Teruo Kawada, Taku Uemura, Joo-Young Lee, Hiroyasu Inoue, Nobuyuki Takahashi, and Yong-Il Kim
- Subjects
Male ,Chromatin Immunoprecipitation ,medicine.medical_specialty ,medicine.drug_class ,Immunoblotting ,Peroxisome proliferator-activated receptor ,White adipose tissue ,Fibrate ,QD415-436 ,Biology ,PPARα ,Biochemistry ,metabolic syndrome ,Mice ,chemistry.chemical_compound ,Endocrinology ,3T3-L1 Cells ,Adipocyte ,Internal medicine ,insulin resistance ,Adipocytes ,medicine ,Animals ,PPAR alpha ,Research Articles ,Cells, Cultured ,adipocyte differentiation ,Adiposity ,chemistry.chemical_classification ,Bezafibrate ,Fatty Acids ,Cell Differentiation ,Cell Biology ,Dietary Fats ,Mice, Inbred C57BL ,chemistry ,Adipogenesis ,Peroxisome proliferator-activated receptor alpha ,Adipocyte hypertrophy ,Oxidation-Reduction ,medicine.drug - Abstract
Peroxisome proliferator-activated receptor-α (PPARα) is a dietary lipid sensor, whose activation results in hypolipidemic effects. In this study, we investigated whether PPARα activation affects energy metabolism in white adipose tissue (WAT). Activation of PPARα by its agonist (bezafibrate) markedly reduced adiposity in KK mice fed a high-fat diet. In 3T3-L1 adipocytes, addition of GW7647, a highly specific PPARα agonist, during adipocyte differentiation enhanced glycerol-3-phosphate dehydrogenase activity, insulin-stimulated glucose uptake, and adipogenic gene expression. However, triglyceride accumulation was not increased by PPARα activation. PPARα activation induced expression of target genes involved in FA oxidation and stimulated FA oxidation. In WAT of KK mice treated with bezafibrate, both adipogenic and FA oxidation-related genes were significantly upregulated. These changes in mRNA expression were not observed in PPARα-deficient mice. Bezafibrate treatment enhanced FA oxidation in isolated adipocytes, suppressing adipocyte hypertrophy. Chromatin immunoprecipitation (ChIP) assay revealed that PPARα was recruited to promoter regions of both adipogenic and FA oxidation-related genes in the presence of GW7647 in 3T3-L1 adipocytes. These findings indicate that the activation of PPARα affects energy metabolism in adipocytes, and PPARα activation in WAT may contribute to the clinical effects of fibrate drugs.
- Published
- 2011
17. Adipogenic effects of prenatal exposure to bisphenol S (BPS) in adult F1 male mice.
- Author
-
Ahn YA, Baek H, Choi M, Park J, Son SJ, Seo HJ, Jung J, Seong JK, Lee J, and Kim S
- Subjects
- Animals, Benzhydryl Compounds, Diet, High-Fat, Female, Male, Mice, Mice, Inbred C57BL, Phenols, Pregnancy, Sulfones, Adipogenesis, Prenatal Exposure Delayed Effects
- Abstract
Bisphenol S (BPS) has been increasingly used as a substitute for bisphenol A (BPA), a known endocrine disruptor. Early-life exposure to BPA affects fetal development and the risk of obesity in adolescence and adulthood. However, the effects of fetal exposure BPS in later life are unknown. This study aimed to investigate the effects of prenatal BPS exposure on adiposity in adult F1 mice. Pregnant C57BL/6 N mice were exposed to BPS (0, 0.05, 0.5, 5, and 50 mg/kg/d) via drinking water from gestation day 9 until delivery. Thereafter, two groups of offspring (6 weeks old) were either administered a standard diet (STD) or a high-fat diet (HFD) for 4 weeks until euthanasia. The body weight and gonadal white adipose tissue (gWAT) mass were determined, and the energy expenditure for the adiposity phenotype was computed especially for male mice, followed by histological analysis of the gWAT. Thereafter, the expression levels of adipogenic marker genes (Pparg, Cebpa, Fabp4, Lpl, and Adipoq) were analyzed in the gWAT via reverse-transcription PCR analysis. BPS-exposed male mice displayed apparent gWAT hypertrophy, consistent with the significant increase in adipocyte size in the gWAT and upregulation of Pparg and its direct target genes among HFD mice in comparison with the control mice. These results suggest that prenatal BPS exposure potentially increases the susceptibility to HFD-induced adipogenesis in male adult mice., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020. Published by Elsevier B.V.)
- Published
- 2020
- Full Text
- View/download PDF
18. Beta-Cryptoxanthin, a Novel Carotenoid Derived from Satsuma Mandarin, Prevents Abdominal Obesity
- Author
-
Katsuyuki Mukai and Katsuhiko Takayanagi
- Subjects
medicine.medical_specialty ,biology ,3T3-L1 ,medicine.disease ,biology.organism_classification ,Obesity ,Citrus unshiu ,Retinoic acid receptor ,Endocrinology ,Internal medicine ,medicine ,Metabolic syndrome ,Adipocyte hypertrophy ,medicine.symptom ,Receptor ,Abdominal obesity - Abstract
Satsuma mandarin ( Citrus unshiu Marc.), a unique Japanese citrus species, is one of the most β-cryptoxanthin (β-CRX)-rich foods in the world. This chapter describes a study in which continuous oral administration of satsuma mandarin-derived β-CRX reduced the body weight of obese mice. Furthermore, β-CRX intake caused a significant reduction in visceral fat. A human clinical trial to evaluate the efficacy of β-CRX was carried out in mildly obese men: results revealed that β-CRX decreased visceral fat, body weight, and waist circumference. Further investigation using 3T3-L1 preadipocytes revealed that β-CRX prevents preadipocyte maturation, adipocyte hypertrophy, and lipid accumulation in mature adipocytes. We also found these effects to be canceled by the addition of LE540, a pan-agonist of the retinoic acid receptor (RAR). These results indicate that β-CRX prevents adipocyte hypertrophy by downregulating peroxisome proliferator-activated receptor gamma (PPAR-γ) via RAR and suppressing mastocytosis. This suggests that β-CRX is effective in obesity prevention and in improving the symptoms of metabolic syndromes.
- Published
- 2014
19. Metabolic Syndrome and Adipokines
- Author
-
Toshimasa Yamauchi and Takashi Kadowaki
- Subjects
medicine.medical_specialty ,Adipose tissue ,Adipokine ,Biology ,medicine.disease ,Energy homeostasis ,Endocrinology ,Insulin resistance ,Diabetes mellitus ,Internal medicine ,medicine ,Resistin ,Adipocyte hypertrophy ,Metabolic syndrome - Abstract
Obesity is defined as an increased mass of adipose tissue conferring a higher risk of cardiovascular and metabolic disorders such as diabetes, hyperlipidemia, and hypertension in the so called «metabolic syndrome». The adipose tissue serves as the site of triglyceride storage. It also participates in the regulation of energy homeostasis as an important endocrine organ that secretes a number of biologically active substances, or «adipokines». Metabolic syndrome is thought to be the result of obesity and obesity-linked insulin resistance. Obesity in adulthood is characterized by adipocyte hypertrophy. Hypertrophic adipocytes show raised insulin resistance causing increased secretion of adipokines such as FFA, TNF-α, and resistin. Increased FFA and TNF-α in turn resulted in increased phosphorylation of IRS-1 and 2 in the serine residues, thereby causing insulin resistance.
- Published
- 2005
20. Antihyperlipidemic and hepatoprotective effects of Gardenin A in cellular and high fat diet fed rodent models.
- Author
-
Toppo E, Darvin SS, Esakkimuthu S, Stalin A, Balakrishna K, Sivasankaran K, Pandikumar P, Ignacimuthu S, and Al-Dhabi NA
- Subjects
- Animals, Cell Survival drug effects, Flavones chemistry, Flavones therapeutic use, Gardenia chemistry, Gardenia metabolism, Hep G2 Cells, Humans, Hyperlipidemias chemically induced, Hyperlipidemias drug therapy, Hyperlipidemias pathology, Hypolipidemic Agents chemistry, Hypolipidemic Agents therapeutic use, Lipids blood, Liver metabolism, Male, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease pathology, Non-alcoholic Fatty Liver Disease prevention & control, Oleic Acid toxicity, Palmitates toxicity, Polyethylene Glycols toxicity, Protective Agents chemistry, Protective Agents therapeutic use, Rats, Rats, Wistar, Diet, High-Fat, Flavones pharmacology, Hypolipidemic Agents pharmacology, Liver drug effects, Protective Agents pharmacology
- Abstract
The gum of Gardenia resinifera Roth., is one of the important drugs used in the Indian system of medicine and a source of unique polymethoxylated flavones. This study was aimed to evaluate the antihyperlipidemic and anti-NAFLD effects of Gardenin A (Gar-A) from G. resinifera gum using in vitro and in vivo models. Gar-A was isolated from G. resinifera gum and was identified on the basis of the physical and spectral data. Toxicity of Gar-A to HepG2 cells was evaluated using MTT assay. The ability of Gar-A to reduce steatosis was assessed using oleate-palmitate induced HepG2 cell lines by estimating the lipid levels by ORO staining and by estimating the intracellular triglyceride content. Effect of Gar-A on amelioration of lipotoxicity was measured by estimating the LDH levels. The doses for in vivo experiments were fixed by Irwin test, between 50 and 100 mg/kg concentrations, through oral route. The acute antihyperlipidemic effect of Gar-A was assessed in Triton WR-1339 induced hyperlipidemic animals. The chronic antihyperlipidemic and anti-NAFLD effects of Gar-A were evaluated in HFD fed rats. In vitro experiments with HepG2 cell line indicated that the cells treated with Gar-A did not show any significant reduction in the viability up to 70 μg/mL concentration. Steatotic HepG2 cells treated with Gar-A showed a significant reduction in lipid accumulation at 2.5-10 μg/mL concentrations. In triton induced hyperlipidemic rats, the treatment significantly reduced the lipid levels at the synthesis phase. The treatment with Gar-A to the HFD fed animals significantly lowered the steatosis and transaminase levels. The other biochemical parameters such as TC, TG, LDL-c, ALP and ACP were also decreased significantly. Treatment with Gar-A significantly lowered the hyperlipidemia and fat accumulation in the liver; detailed molecular investigations are necessary to establish the antihyperlipidemic and hepatoprotective potentials of Gar-A., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
21. Developmental regulation of adipose tissue growth through hyperplasia and hypertrophy in the embryonic Leghorn and broiler.
- Author
-
Chen P, Suh Y, Choi YM, Shin S, and Lee K
- Subjects
- Adipose Tissue cytology, Animals, Avian Proteins metabolism, Chick Embryo, Chickens metabolism, Gene Expression Regulation, Developmental, Hyperplasia, Hypertrophy, Adipose Tissue embryology, Avian Proteins genetics, Chickens genetics
- Abstract
The United States is a world leader in poultry production, which is the reason why achieving better performance and muscle growth each year is a necessity. Reducing accretion of adipose tissue is another important factor for poultry producers because this allows more nutrients to be directed toward muscle growth, but the effect of embryonic adipose growth on posthatch development has not been fully understood. The purpose of this study was to investigate the total DNA mass, morphological characteristics, differentiation markers, and triglyceride breakdown factors of embryonic adipose tissue, and their relation to hyperplastic and hypertrophic growth within layers (Leghorn) and meat-type chickens (broilers). After embryonic day (E) 12, broiler weight was significantly higher than Leghorn, and this trend continued throughout the rest of incubation and posthatch (P < 0.05). Neck and leg fat pad weights between the 2 breeds did not differ at most of the time points. A remarkable increase in total DNA mass was observed between E12 and E14 in both Leghorn and broilers (P < 0.05), indicating a high potential for hyperplastic growth during this time. Histological analysis revealed clusters of preadipocytes at E12; however, the majority of these cells differentiated by E14 and continued to grow until the time of hatch. The adipocyte sizes between both breeds did not generally differ, even though broilers are known to have larger adipocytes posthatch. Fatty acid-binding protein 4 expression levels in Leghorn and broilers continued to rise with each time point, which paralleled the expansion of mature adipocytes. Adipose triglyceride lipase was highly expressed at E20 and d 1 posthatch to mobilize triglyceride degradation for energy during hatching. Thus, embryonic chicken adipose tissue was found to develop by hyperplastic mechanisms followed by hypertrophy. At embryonic stages and early posthatch, layer- and meat-type chicken adipose growth does not differ, which suggests breed differences occur posthatch., (© 2014 Poultry Science Association Inc.)
- Published
- 2014
- Full Text
- View/download PDF
22. Avian adipose tissue: growth and metabolism
- Author
-
S.C. Butterwith
- Subjects
medicine.medical_specialty ,Broiler ,Adipose tissue ,Metabolism ,White adipose tissue ,Biology ,Hyperplasia ,medicine.disease ,Fat pad ,Muscle hypertrophy ,Endocrinology ,Internal medicine ,medicine ,Adipocyte hypertrophy - Abstract
Publisher Summary The growth of adipose tissue is a result of hypertrophy and hyperplasia. This chapter examines the contributions of hyperplasia and hypertrophy to adipose tissue growth and discusses the regulators involved in lipid accumulation and release, and in the control of cell number. At a given age in the broiler, there is a high correlation between the fat content of the carcass and adipose cell size. Adipose tissue cell size and number are also influenced by diet. Feeding a high protein diet produces a smaller abdominal fat pad. Fat pad weight was inversely related to dietary protein concentrations, between 20% and 35%, and these differences were because of changes in both cell size and number. Studies on adipose tissue cellularity are descriptive, and although they provide information on when adipocyte hypertrophy and hyperplasia are occurring, they provide little information about the regulation of these processes. This chapter also discusses various processes involved to identify important sites of regulation.
- Published
- 1988
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.